Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
12301
Great Elm Group
GEG
$64.2M
| $57.8K | ﹤0.01% |
30,906
+313
| +1% | +$668 |
2025 Q1
4 quarters
|
|
|
XYF
12302
X Financial
XYF
$182M
| $57.8K | ﹤0.01% |
14,023
-127,706
| -90% | -$662K |
2025 Q4
1 quarter
|
|
|
GHG
12303
GreenTree Hospitality
GHG
$94.8M
| $57.8K | ﹤0.01% |
45,838
+13,612
| +42% | +$19.6K |
2025 Q1
4 quarters
|
|
12304
PUT
Future Fuel
FF
$226M
| $57.8K | ﹤0.01% |
+15,000
| New | +$56.3K |
2026 Q1
0 quarters
|
|
|
SNBR
12305
CALL
DELISTED
Sleep Number
SNBR
| $57.6K | ﹤0.01% |
32,100
-18,100
| -36% | -$136K |
2018 Q3
30 quarters
|
|
12306
CALL
AC Immune
ACIU
$271M
| $57.5K | ﹤0.01% |
20,900
-29,600
| -59% | -$91.9K |
2025 Q4
1 quarter
|
|
12307
Neonode
NEON
$15.5M
| $57.3K | ﹤0.01% |
40,949
+30,877
| +307% | +$53.4K |
2025 Q3
2 quarters
|
|
12308
PUT
Veru
VERU
$42.8M
| $56.6K | ﹤0.01% |
25,600
+4,900
| +24% | +$11.9K |
2020 Q4
21 quarters
|
|
12309
CALL
Red Robin
RRGB
$150M
| $56.5K | ﹤0.01% |
+19,300
| New | +$72.5K |
2026 Q1
0 quarters
|
|
12310
CALL
ZipRecruiter
ZIP
$292M
| $56.3K | ﹤0.01% |
30,600
-30,700
| -50% | -$75.3K |
2021 Q3
18 quarters
|
|
|
CYPH
12311
PUT
Cypherpunk Technologies Inc
CYPH
$327M
| $56.3K | ﹤0.01% |
70,800
+29,800
| +73% | +$23K |
2021 Q4
17 quarters
|
|
12312
PUT
Gossamer Bio
GOSS
$65.5M
| $56.2K | ﹤0.01% |
2,140
-1
| -0% | -$126 |
2022 Q3
14 quarters
|
|
12313
CALL
Protalix BioTherapeutics
PLX
$218M
| $56.2K | ﹤0.01% |
25,900
+8,900
| +52% | +$22.1K |
2025 Q4
1 quarter
|
|
12314
FingerMotion
FNGR
$18.9M
| $56.2K | ﹤0.01% |
+56,448
| New | +$67.4K |
2026 Q1
0 quarters
|
|
12315
PMV Pharmaceuticals
PMVP
$95.7M
| $55.9K | ﹤0.01% |
45,048
-73,545
| -62% | -$93.5K |
2020 Q3
22 quarters
|
|
|
EMPD
12316
CALL
Empery Digital
EMPD
$88.1M
| $55.8K | ﹤0.01% |
+13,200
| New | +$57.1K |
2026 Q1
0 quarters
|
|
12317
Pyxis Tankers
PXS
$79.1M
| $55.8K | ﹤0.01% |
13,161
-42,174
| -76% | -$154K |
2025 Q2
3 quarters
|
|
12318
CALL
Lineage Cell Therapeutics
LCTX
$235M
| $55.8K | ﹤0.01% |
35,300
+22,800
| +182% | +$38.4K |
2022 Q4
13 quarters
|
|
|
SRTA
12319
PUT
Strata Critical Medical Inc
SRTA
$418M
| $55.6K | ﹤0.01% |
13,300
-1,100
| -8% | -$5.29K |
2021 Q1
20 quarters
|
|
12320
Performance Shipping
PSHG
$21M
| $55.4K | ﹤0.01% |
30,134
+18,706
| +164% | +$39.1K |
2025 Q3
2 quarters
|
|
12321
CALL
Blue Ridge Bankshares
BRBS
$352M
| $55.4K | ﹤0.01% |
+13,200
| New | +$55.2K |
2026 Q1
0 quarters
|
|
|
JF
12322
J and Friends Holdings
JF
$16.9M
| $55.4K | ﹤0.01% |
+60,245
| New | +$57.9K |
2026 Q1
0 quarters
|
|
12323
CALL
Tilly's
TLYS
$140M
| $54.7K | ﹤0.01% |
13,500
-17,500
| -56% | -$35.3K |
2025 Q2
3 quarters
|
|
12324
PUT
Westwater Resources
WWR
$65.4M
| $54.6K | ﹤0.01% |
83,500
-94,600
| -53% | -$85.2K |
2025 Q3
2 quarters
|
|
12325
Singularity Future Technology
SGLY
$3.95M
| $54.6K | ﹤0.01% |
+9,374
| New | +$65.2K |
2026 Q1
0 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.